Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.

By R. Nam, R. Saskin, Yuna Lee, Ying Liu, C. Law, L. Klotz, D. Loblaw, J. Trachtenberg, A. Stanimirovic, A. E. Simor and 3 more. Journal of Urology, 2010

597 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Rheumatology, Urology

View Paper: https://www.semanticscholar.org/paper/76d366380c23cfd141020fecfb0ae7fca2eac26f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. E. Klein
2. C. Magi-Galluzzi
3. J. Simko
4. S. Falzarano
5. T. Maddala
6. J. Chan
7. Jianbo Li
8. J. Cowan

Citations in the corpus

• A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. (2014, background): “Serial prostate biopsies are uncomfortable and are associated with risks of bleeding, serious infection [46] and other adverse consequences [47].”
• Systematic review of complications of prostate biopsy. (2013, unknown): “reported a rise in urologic complication rates amongst 75 190 men undergoing TRUS-Bx in Canada between 1996 and 2005 [4].”